Cell MedX Corp. Quarterly Cash and Cash Equivalents, at Carrying Value in USD from Q3 2010 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Cell MedX Corp. quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q3 2010 to Q1 2022.
  • Cell MedX Corp. Cash and Cash Equivalents, at Carrying Value for the quarter ending February 28, 2022 was $30.7K, a 18.4% increase year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $30.7K +$4.77K +18.4% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $37.1K +$15.4K +70.5% Nov 30, 2021 10-Q 2022-01-12
Q3 2021 $63.8K -$56.7K -47.1% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $20.8K -$24.3K -54% May 31, 2021 10-Q 2022-04-11
Q1 2021 $26K -$87.1K -77% Feb 28, 2021 10-Q 2022-04-11
Q4 2020 $21.8K -$253K -92.1% Nov 30, 2020 10-Q 2022-01-12
Q3 2020 $120K -$232K -65.8% Aug 31, 2020 10-Q 2021-10-14
Q2 2020 $45.1K -$12.1K -21.1% May 31, 2020 10-Q 2022-04-11
Q1 2020 $113K -$17.8K -13.6% Feb 29, 2020 10-Q 2021-04-09
Q4 2019 $275K +$251K +1028% Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $353K +$339K +2477% Aug 31, 2019 10-Q 2020-10-15
Q2 2019 $57.2K +$49K +597% May 31, 2019 10-K 2021-08-30
Q1 2019 $131K +$107K +444% Feb 28, 2019 10-Q 2020-04-14
Q4 2018 $24.4K -$84K -77.5% Nov 30, 2018 10-Q 2020-01-14
Q3 2018 $13.7K -$312K -95.8% Aug 31, 2018 10-Q 2019-10-15
Q2 2018 $8.2K -$59.3K -87.9% May 31, 2018 10-K 2020-09-15
Q1 2018 $24K +$14.9K +163% Feb 28, 2018 10-Q 2019-04-22
Q4 2017 $108K -$9.61K -8.15% Nov 30, 2017 10-Q 2019-01-14
Q3 2017 $326K +$288K +759% Aug 31, 2017 10-Q/A 2018-10-16
Q2 2017 $67.5K +$39.9K +145% May 31, 2017 10-K 2019-09-06
Q1 2017 $9.14K -$5.66K -38.2% Feb 28, 2017 10-Q 2018-04-16
Q4 2016 $118K +$116K +7546% Nov 30, 2016 10-Q 2018-01-16
Q3 2016 $38K +$31.1K +455% Aug 31, 2016 10-Q 2017-10-17
Q2 2016 $27.6K +$26.3K +2091% May 31, 2016 10-K 2018-09-13
Q1 2016 $14.8K -$14.1K -48.8% Feb 29, 2016 10-Q 2017-04-14
Q4 2015 $1.54K +$1.2K +355% Nov 30, 2015 10-Q 2017-01-17
Q3 2015 $6.84K Aug 31, 2015 10-Q 2016-10-17
Q2 2015 $1.26K +$57.00 +4.75% May 31, 2015 10-K 2017-08-29
Q1 2015 $28.9K +$27.7K +2307% Feb 28, 2015 10-Q 2016-04-14
Q4 2014 $339 -$1.93K -85.1% Nov 30, 2014 10-Q 2016-01-14
Q2 2014 $1.2K -$9.78K -89.1% May 31, 2014 10-K 2015-09-03
Q1 2014 $1.2K -$11.4K -90.5% Feb 28, 2014 10-Q 2015-04-14
Q4 2013 $2.27K -$16.6K -88% Nov 30, 2013 10-Q 2015-01-14
Q3 2013 $5.31K -$18.3K -77.5% Aug 31, 2013 10-Q 2014-10-09
Q2 2013 $11K -$12.6K -53.5% May 31, 2013 10-K 2014-08-26
Q1 2013 $12.6K -$17.4K -58.1% Feb 28, 2013 10-Q/A 2014-07-17
Q4 2012 $18.9K +$18.9K Nov 30, 2012 10-Q 2014-01-13
Q3 2012 $23.6K +$23.6K Aug 31, 2012 10-Q 2013-10-03
Q2 2012 $23.6K +$23.6K May 31, 2012 10-K/A 2014-07-17
Q1 2012 $30K +$17.1K +133% Feb 29, 2012 10-Q 2013-04-15
Q4 2011 $17.00* -$14.6K Nov 30, 2011 10-Q 2013-01-16
Q3 2011 $17.00* -$14.6K Aug 31, 2011 10-Q 2012-10-15
Q2 2011 $17.00* May 31, 2011 10-K 2012-10-11
Q1 2011 $12.9K Feb 28, 2011 10-Q 2012-04-09
Q4 2010 $14.6K Nov 30, 2010 10-Q 2012-03-02
Q3 2010 $14.6K Aug 31, 2010 10-Q 2011-10-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.